Myelodysplastic syndromes standardized response criteria: further definition
- PMID: 11535540
- DOI: 10.1182/blood.v98.6.1985
Myelodysplastic syndromes standardized response criteria: further definition
Comment on
-
Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: evidence for in vivo synergy.Blood. 1996 May 15;87(10):4076-81. Blood. 1996. PMID: 8639764 Clinical Trial.
-
International scoring system for evaluating prognosis in myelodysplastic syndromes.Blood. 1997 Mar 15;89(6):2079-88. Blood. 1997. PMID: 9058730
-
Stimulation of hematopoiesis by amifostine in patients with myelodysplastic syndrome.Blood. 1997 Nov 1;90(9):3364-9. Blood. 1997. PMID: 9345018 Clinical Trial.
-
Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patients.Blood. 1998 Jul 1;92(1):68-75. Blood. 1998. PMID: 9639501 Clinical Trial.
-
Report of an international working group to standardize response criteria for myelodysplastic syndromes.Blood. 2000 Dec 1;96(12):3671-4. Blood. 2000. PMID: 11090046
-
Improve or abandon the standardized response criteria for myelodysplastic syndromes recommended by the International Working Group.Blood. 2001 Jul 1;98(1):251-2. doi: 10.1182/blood.v98.1.251. Blood. 2001. PMID: 11439977 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical

